Joseph Iv Griffith Sells 11,459 Shares of 908 Devices (NASDAQ:MASS) Stock

908 Devices Inc. (NASDAQ:MASSGet Free Report) CFO Joseph Iv Griffith sold 11,459 shares of the stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $10.95, for a total value of $125,476.05. Following the transaction, the chief financial officer owned 121,497 shares of the company’s stock, valued at $1,330,392.15. This represents a 8.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Stock Performance

MASS stock opened at $10.73 on Friday. The firm has a fifty day moving average price of $8.76 and a 200 day moving average price of $7.69. 908 Devices Inc. has a fifty-two week low of $5.03 and a fifty-two week high of $11.25. The firm has a market cap of $443.47 million, a PE ratio of -11.29 and a beta of 0.66.

908 Devices (NASDAQ:MASSGet Free Report) last released its quarterly earnings data on Tuesday, August 11th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.03. 908 Devices had a negative net margin of 56.96% and a negative return on equity of 12.54%. The business had revenue of $16.07 million during the quarter, compared to analyst estimates of $15.37 million. On average, equities analysts predict that 908 Devices Inc. will post -0.8 EPS for the current year.

Analysts Set New Price Targets

MASS has been the topic of several analyst reports. Stifel Nicolaus boosted their target price on 908 Devices from $10.00 to $12.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Wall Street Zen upgraded 908 Devices from a “hold” rating to a “buy” rating in a research report on Saturday. Roth Capital lifted their price objective on shares of 908 Devices from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Wednesday, August 12th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of 908 Devices in a research report on Friday, August 7th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, 908 Devices currently has an average rating of “Hold” and an average target price of $12.50.

Check Out Our Latest Stock Analysis on 908 Devices

Hedge Funds Weigh In On 908 Devices

Several hedge funds have recently bought and sold shares of MASS. Legal & General Group Plc purchased a new stake in shares of 908 Devices during the second quarter valued at $27,000. Allworth Financial LP purchased a new position in 908 Devices in the 2nd quarter worth about $29,000. California State Teachers Retirement System lifted its holdings in 908 Devices by 128.3% during the 2nd quarter. California State Teachers Retirement System now owns 3,384 shares of the company’s stock valued at $29,000 after buying an additional 1,902 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in 908 Devices in the 2nd quarter valued at about $48,000. Finally, Intelligence Driven Advisers LLC bought a new position in 908 Devices in the 1st quarter worth about $61,000. Institutional investors own 88.06% of the company’s stock.

908 Devices Company Profile

(Get Free Report)

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.

Featured Articles

Insider Buying and Selling by Quarter for 908 Devices (NASDAQ:MASS)

Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.